person

Antje W.

Country
Germany
Department
TBC

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
56
Sites with multiple studies

Has run more than one trial at 56 of 111 partner sites.

Specializations

Neuro-Oncology Focus

This investigator specializes in treating various forms of brain tumors, with particular emphasis on glioblastoma and progressive gliomas. Their research encompasses both newly diagnosed and recurrent cases, exploring innovative therapeutic approaches.

  • Primary Brain Tumors
  • Malignant Gliomas
  • Meningioma Management

Their work includes evaluation of targeted therapies for specific molecular subtypes of brain tumors.

Molecular Targeted Therapies

The investigator focuses on personalized treatment approaches targeting specific genetic mutations, including IDH1/IDH2 mutations and BRAF alterations in brain tumors. Their research explores novel therapeutic agents designed for specific molecular profiles.

  • Mutation-Specific Treatments
  • Targeted Drug Development
  • Biomarker Studies

Their expertise extends to developing treatment strategies for tumors with specific genetic signatures.

Therapeutic Innovation

The investigator's work encompasses multiple therapeutic modalities, including peptide vaccines, radiotherapy combinations, and novel drug combinations. They are involved in evaluating new treatment approaches for resistant or progressive brain tumors.

  • Immunotherapy Applications
  • Combination Therapies
  • Treatment Resistance

Their research includes investigating innovative treatment strategies for challenging brain tumor cases.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.